Connection

Pierre Giglio to Adult

This is a "connection" page, showing publications Pierre Giglio has written about Adult.
Connection Strength

0.228
  1. Early assessment of recurrent glioblastoma response to bevacizumab treatment by diffusional kurtosis imaging: a preliminary report. Neuroradiol J. 2019 Oct; 32(5):317-327.
    View in: PubMed
    Score: 0.046
  2. Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma. Cancer. 2012 Jul 15; 118(14):3599-606.
    View in: PubMed
    Score: 0.027
  3. Syncope and head CT scans in the emergency department. Emerg Radiol. 2005 Dec; 12(1-2):44-6.
    View in: PubMed
    Score: 0.018
  4. Neoplastic meningitis in patients with adenocarcinoma of the gastrointestinal tract. Cancer. 2005 Jun 01; 103(11):2355-62.
    View in: PubMed
    Score: 0.017
  5. Response of neoplastic meningitis from solid tumors to oral capecitabine. J Neurooncol. 2003 Nov; 65(2):167-72.
    View in: PubMed
    Score: 0.016
  6. Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study. Clin Cancer Res. 2022 06 01; 28(11):2270-2277.
    View in: PubMed
    Score: 0.014
  7. Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas. PLoS One. 2020; 15(12):e0244383.
    View in: PubMed
    Score: 0.013
  8. False-positive 1p/19q Testing Results in Gliomas: Clinical and Research Consequences. Am J Clin Oncol. 2020 11; 43(11):802-805.
    View in: PubMed
    Score: 0.013
  9. A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma. Neuro Oncol. 2020 10 14; 22(10):1505-1515.
    View in: PubMed
    Score: 0.013
  10. Perilesional apparent diffusion coefficient in the preoperative evaluation of glioma grade. Clin Imaging. 2018 Nov - Dec; 52:88-94.
    View in: PubMed
    Score: 0.011
  11. Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma. Neuro Oncol. 2015 Feb; 17(2):266-73.
    View in: PubMed
    Score: 0.008
  12. Neurological deficits during treatment with tumor necrosis factor-alpha antagonists. Am J Med Sci. 2011 Nov; 342(5):352-5.
    View in: PubMed
    Score: 0.007
  13. A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma. Neuro Oncol. 2010 Nov; 12(11):1167-72.
    View in: PubMed
    Score: 0.006
  14. High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas. J Neurooncol. 2009 Jul; 93(3):343-8.
    View in: PubMed
    Score: 0.006
  15. Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme. Neuro Oncol. 2008 Apr; 10(2):216-22.
    View in: PubMed
    Score: 0.005
  16. Brain tumors in individuals with familial adenomatous polyposis: a cancer registry experience and pooled case report analysis. Cancer. 2007 Feb 15; 109(4):761-6.
    View in: PubMed
    Score: 0.005
  17. Case files from the University of Chicago's Sleep Disorders Center. Case 1: a gigantic fatigue. MedGenMed. 2004 Apr 02; 6(2):50.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.